Publications Repository

Publications Repository

View item 
  •   Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
  • Home
  • ICR Divisions
  • Cancer Therapeutics
  • View item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Glutathione Metabolism: An Achilles' Heel of ARID1A-Deficient Tumors.

Thumbnail
View/Open
Published version (490.6Kb)
Date
2019-02
ICR Author
Gorrini, Chiara
Author
Gorrini, C
Mak, TW
Type
Journal Article
Metadata
Show full item record
Abstract
In this issue of Cancer Cell, Ogiwara et al. describe a novel link between the epigenetic regulator ARID1A and glutathione metabolism in cancer that is mediated by regulation of the cystine/glutamate transporter XCT. This work reveals that synthesis of reduced glutathione is a metabolic dependency of cancers with ARID1A-inactivating mutations.
URI
https://repository.icr.ac.uk/handle/internal/4103
DOI
https://doi.org/10.1016/j.ccell.2019.01.017
Collections
  • Cancer Therapeutics
Subject
Humans
Neoplasms
Glutathione
Amino Acid Transport System y+
Nuclear Proteins
Transcription Factors
Mutation
Research team
Target Evaluation and Molecular Therapeutics
Language
eng
License start date
2019-02
Citation
Cancer cell, 2019, 35 (2), pp. 161 - 163

Browse

All of ICR repositoryICR DivisionsBy issue dateAuthorsTitlesPublication TypesThis collectionBy issue dateAuthorsTitlesPublication Types
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.